frontline immunotherapy in advanced bladder cancer
Published 6 years ago • 199 plays • Length 3:36Download video MP4
Download video MP3
Similar videos
-
0:43
dr. rosenberg on frontline immunotherapy potential in bladder cancer
-
3:13
frontline atezolizumab for advanced bladder cancer
-
3:41
impact of immunotherapy in advanced bladder cancer
-
1:30
dr. braun on frontline immunotherapy in advanced rcc
-
0:44
role of immunotherapy in bladder cancer
-
6:35
immunotherapy in second-line advanced bladder cancer
-
0:55
dr. siefker-radtke on fda approval of frontline atezolizumab in bladder cancer
-
1:10
dr. wright on frontline considerations in locally advanced bladder cancer
-
1:49
dr. herbst on the impact of frontline immunotherapy in lung cancer
-
6:45
activity of immunotherapy in the frontline setting
-
1:08
incorporating immunotherapy in the frontline treatment of patients with bladder cancer
-
1:09
dr. plimack on frontline pembrolizumab for urothelial carcinoma
-
0:59
dr. galsky on progression on immunotherapy in bladder cancer
-
1:56
analyzing frontline options for patients with bladder cancer
-
6:49
fda approval of atezolizumab for advanced bladder cancer
-
1:13
dr. bellmunt on challenges with immunotherapy in bladder cancer
-
2:03
dr. sonpavde on immunotherapy after progression in advanced bladder cancer
-
1:48
dr. brahmer discusses frontline single-agent pembrolizumab in lung cancer
-
2:06
dr. bellmunt highlights immunotherapy options in bladder cancer